Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist

Environ Health Perspect. 1991 Jun:93:97-103. doi: 10.1289/ehp.919397.

Abstract

Gene transfer experiments have defined limitations with regard to the ability of individual oncogenes to transform cultured cells to a tumorigenic state. The stable transformation of REF52 cells by either the ras or sis oncogenes requires the continuous expression of a second collaborating oncogene, such as adenovirus-5 E1A or SV40 large T-antigen. Our studies suggest that the function of the nuclear collaborators is to antagonize dominant growth controls which limit the ability of REF52 cells to proliferate in response to mitogenic stimuli.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adenovirus Early Proteins
  • Animals
  • Antigens, Polyomavirus Transforming / genetics
  • Antigens, Polyomavirus Transforming / physiology
  • Cell Line
  • Cell Line, Transformed
  • Cell Transformation, Neoplastic / genetics*
  • Cricetinae
  • Epistasis, Genetic*
  • Fibroblasts
  • Gene Expression Regulation, Neoplastic*
  • Genes, Retinoblastoma
  • Genes, ras
  • Genetic Complementation Test
  • Hybrid Cells
  • Mesocricetus
  • Mice
  • Mice, Nude
  • Neoplasms, Experimental / genetics
  • Oncogene Proteins, Viral / genetics
  • Oncogene Proteins, Viral / physiology
  • Oncogenes*
  • Phenotype
  • Platelet-Derived Growth Factor / genetics
  • Platelet-Derived Growth Factor / physiology
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / physiology
  • Proto-Oncogene Proteins c-sis
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Proto-Oncogene Proteins p21(ras) / physiology
  • Rats / embryology

Substances

  • Adenovirus Early Proteins
  • Antigens, Polyomavirus Transforming
  • Oncogene Proteins, Viral
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-sis
  • Proto-Oncogene Proteins p21(ras)